Pages
Products
Support
CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER

Research Resource

Creative Biogene is committed to providing high quality products and services to help scientists around the world find solutions in biological research and drug discovery.

Research Areas

sgRNA Library for Precise Targeting and Efficient Editing

sgRNA Library for Precise Targeting and Efficient Editing

Creative Biogene introduced customers to the characteristics of different sgRNA libraries, the sgRNA library construction process, advantages and applications.

Clinical Perspectives and Recent Advances in mRNA Vaccines

Clinical Perspectives and Recent Advances in mRNA Vaccines

Creative Biogene presented to the client about the potential biological mechanisms of mRNA vaccines and their applications in a number of infectious diseases and cancers.

ADC Process Development and Manufacturing (Part I): Core Components, Intermediates, and Conjugation Strategies

ADC Process Development and Manufacturing (Part I): Core Components, Intermediates, and Conjugation Strategies

This chapter outlines key strategies in ADC development, covering core components, conjugation methods, quality control, and process optimization to ensure the consistent, safe, and effective manufacture of antibody-drug conjugates.

ADC Process Development and Manufacturing (Part II): Purification Strategies and Production Equipment

ADC Process Development and Manufacturing (Part II): Purification Strategies and Production Equipment

This part explores purification strategies and production equipment in ADC manufacturing. It highlights key methods like UF/DF and chromatography for impurity removal and discusses equipment considerations, including single-use vs. reusable systems, to ensure safety, efficiency, and scalability in handling highly potent compounds.

Vaccine Production Processes

Vaccine Production Processes

Vaccines represent the most economical and effective method for preventing infectious diseases. Modern vaccine technology has evolved beyond traditional pathogen isolation and inactivation to incorporate genetic engineering, immunology, and systems biology. Contemporary production processes include recombinant proteins, virus-like particles, polysaccharide conjugates, viral vectors, inactivated pathogens, DNA vaccines, and mRNA platforms, addressing complex emerging pathogens and expanding therapeutic applications.